CV Lattes
ORCID
Google Scholar Citations
Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. Escola Paulista de Medicina (EPM) (Institutional affiliation from the last research proposal) Birthplace: Brazil
I'm graduated in Biomedical science and PhD in Biomedical engineering, my research studies involve the neuroprotective effects of biodevices containing distinct drugs focusing on Alzheimer's disease therapy. I am currently carrying out a postdoctoral degree in bioprinting models of Alzheimer's disease. I primarily act on the following areas: Nanotechnology, utrathin fibers, anti diabetic drugs, Alzheimer's disease, type 2 diabetes, cancer, cell culture, photodynamic therapy, cell adhesion, led. My research projects involve the development of biomaterials and the use of different drugs for the treatment of neurodegenerative (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Animal models are considered the gold standard for Blood-Brain-Barrier (BBB) function studies. Although the use of in vivo models has contributed significantly to the advancement of the physiopathology of diseases that affect the BBB, they are limited regarding physiological differences between humans and rodents. To solve this problem, in vitro models have been proposed and developed, bu…
Alzheimer's Disease (AD) is a neurodegenerative pathology that affects 36 million people worldwide. Type 2 Diabetes Mellitus (T2DM) is a risk factor for AD, as this dementia has been linked to impaired insulin signalling in the brain, consequently, drugs that enhance this signalling may have therapeutic potential for AD. Several studies have shown that GLP-1 (glucagon-like peptide-1) and …
Photodynamic therapy (PDT) is a therapeutic modality for the treatment of neoplastic diseases and non-neoplastic characterized by overgrowth of unwanted or abnormal cells. This therapy involves the activation by light in the presence of molecular oxygen, certain dyes (photosensitizers) that are somehow selectively absorbed by the target tissue. This process has been used as a palliative t…
| 3 / 3 | Completed scholarships in Brazil |
| Associated processes | |